NASDAQ$AZTA
Azenta Inc · Q3 2023 earnings
Q3 2023 earnings · · Investor relations
Briefing
Revenue increased by 25% year over year and 12% sequentially, driven by growth in both Life Sciences Products and Services.
Azenta reported a strong Q3 2023 with revenue of $166 million, a 25% increase year-over-year. The company saw positive momentum in both organic revenue growth and profitability, driven by go-to-market initiatives and cost reduction efforts. Positive free cash flow was generated during the quarter.
- Revenue was $166 million, up 25% year over year and 12% sequentially.
- Organic revenue increased 2% year over year.
- Life Sciences Products revenue was $75 million, up 57% year over year, including $27 million from B Medical.
- Life Sciences Services revenue was $91 million, up 7% year over year.
Headline financials
Revenue & EPS history
Azenta · Revenue · Quarterly
$166M
Forward guidance
The Company announced revenue and earnings guidance for the fourth quarter of fiscal 2023. Total revenue is expected to be in the range of $155 to $173 million. Non-GAAP diluted earnings per share is expected to be in the range of ($0.02) to $0.06. GAAP diluted earnings per share from continuing operations is expected to be in the range of ($0.20) to ($0.12). For the full year, the Company is narrowing its expectation for revenue to be in the range of $648 to $665 million, consistent with growth of approximately 17% to 20% year over year.
Tailwinds
- Total revenue is expected to be in the range of $155 to $173 million.
- Life Sciences Services revenue is expected to be in the range of $86 to $94 million.
- Life Sciences Products revenue excluding B Medical is expected to be in the range of $45 to $55 million.
- B Medical revenue is expected to be approximately $24 million.
- For the full year, the Company is narrowing its expectation for revenue to be in the range of $648 to $665 million, consistent with growth of approximately 17% to 20% year over year.
Headwinds
- Non-GAAP diluted earnings per share is expected to be in the range of ($0.02) to $0.06.
- GAAP diluted earnings per share from continuing operations is expected to be in the range of ($0.20) to ($0.12).
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q3 2023
-0.6%
Avg return
Earnings day
-0.1%
Avg return
5 days after
+0.4%
Avg return
30 days after
43%
28 / 65 earnings
Positive
+22.4%
Q4 2025
Best reaction
-23.4%
Q1 2026
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q2 2026 | -21.6% | -21.0% | -6.1% | |
| Q1 2026 | -23.4% | -19.3% | -34.2% | |
| Q4 2025 | +22.4% | +20.9% | +14.8% | |
| Q2 2025 | -0.7% | +11.3% | +13.1% | |
| Q1 2025 | +3.4% | -8.6% | -16.0% | |
| Q4 2024 | -2.9% | -9.4% | +0.2% | |
| Q3 2024 | -4.9% | -1.1% | -15.4% | |
| Q2 2024 | -4.8% | -6.9% | -2.1% | |
| Q1 2024 | -4.0% | -1.2% | -2.0% | |
| Q4 2023 | +14.6% | +16.1% | +27.2% | |
| Q3 2023 | +21.8% | +18.4% | +11.0% | |
| Q2 2023 | -19.8% | -11.1% | +0.0% | |
| Q1 2023 | -20.8% | -22.2% | -29.7% | |
| Q4 2022 | +15.8% | +17.5% | +25.8% | |
| Q3 2022 | -10.3% | -8.7% | -23.8% | |
| Q2 2022 | -4.0% | +5.6% | +8.9% | |
| Q1 2022 | +5.6% | -3.1% | -7.0% | |
| Q4 2021 | -7.6% | -7.1% | -16.7% | |
| Q3 2021 | -4.0% | -4.0% | -3.5% | |
| Q2 2021 | -7.3% | -7.1% | -2.9% | |
| Q1 2021 | -2.8% | -0.3% | -4.2% | |
| Q4 2020 | +9.7% | +12.8% | +19.9% | |
| Q3 2020 | +17.8% | +21.2% | +13.2% | |
| Q2 2020 | -15.4% | -12.3% | -3.9% | |
| Q1 2020 | -1.4% | +6.7% | -15.1% | |
| Q4 2019 | +7.8% | +5.5% | -7.7% | |
| Q3 2019 | -15.7% | -17.0% | -14.1% | |
| Q2 2019 | +18.5% | +23.4% | +15.6% | |
| Q1 2019 | +0.9% | -5.3% | -0.4% | |
| Q4 2018 | -11.6% | -10.9% | -13.6% | |
| Q3 2018 | -7.2% | -5.8% | +22.3% | |
| Q2 2018 | +8.4% | +12.5% | +31.4% | |
| Q1 2018 | -3.4% | -9.5% | -2.4% | |
| Q4 2017 | -23.3% | -21.2% | -28.8% | |
| Q3 2017 | -8.1% | +0.9% | +6.6% | |
| Q2 2017 | +6.0% | +9.4% | +16.3% | |
| Q1 2017 | +16.9% | +20.6% | +20.0% | |
| Q4 2016 | +7.7% | +11.7% | +20.1% | |
| Q3 2016 | -3.3% | -5.4% | -1.7% | |
| Q2 2016 | -7.3% | — | — | |
| Q1 2016 | -1.7% | — | — | |
| Q4 2015 | -0.2% | — | — | |
| Q3 2015 | +11.2% | — | — | |
| Q2 2015 | -0.5% | — | — | |
| Q1 2015 | -5.1% | — | — | |
| Q4 2014 | +6.0% | — | — | |
| Q3 2014 | +2.7% | — | — | |
| Q2 2014 | +1.1% | — | — | |
| Q1 2014 | -1.3% | — | — | |
| Q4 2013 | +2.9% | — | — | |
| Q3 2013 | -4.0% | — | — | |
| Q2 2013 | +2.7% | — | — | |
| Q1 2013 | +2.5% | — | — | |
| Q4 2012 | +1.3% | — | — | |
| Q3 2012 | -13.8% | — | — | |
| Q2 2012 | -1.1% | — | — | |
| Q1 2011 | +7.2% | — | — | |
| Q1 2012 | +7.2% | — | — | |
| Q4 2009 | +2.8% | — | — | |
| Q2 2011 | +2.8% | — | — | |
| Q4 2011 | +2.8% | — | — | |
| Q4 2010 | -0.1% | — | — | |
| Q3 2010 | -0.1% | — | — | |
| Q3 2011 | -0.1% | — | — | |
| Q2 2010 | -6.9% | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro